TP53 and CDKN2A Mutations Correlate with Survival, Stage, and Grade in Mesothelioma

被引：0
|
作者：
Zhu, Allen [1 ]
Husain, Aliya [1 ]
Hermina, Andrew [1 ]
Mueller, Jeffrey [2 ]
Kwon, Jung Woo [2 ]
机构：
[1] Univ Chicago, Chicago, IL USA
[2] Univ Chicago, Med Ctr, Chicago, IL USA
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1592
引用
收藏
页码：S1972 / S1973
页数：2
相关论文
共 50 条
  • [1] Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL
    Cobbers, JMJL
    Wolter, M
    Reifenberger, J
    Ring, GU
    Jessen, F
    An, HX
    Niederacher, D
    Schmidt, EE
    Ichimura, K
    Floeth, F
    Kirsch, L
    Borchard, F
    Louis, DN
    Collins, VP
    Reifenberger, G
    BRAIN PATHOLOGY, 1998, 8 (02) : 263 - 276
  • [2] Concurrent mutation of CDKN2A and TP53 loci in primary keratinocytes
    Li, Bin
    Mroz, Edmund A.
    Rocco, James W.
    CANCER RESEARCH, 2017, 77
  • [3] TP53 and CDKN2a Mutations in Never-Smoker Oral Tongue Squamous Cell Carcinoma
    Heaton, Chase M.
    Durr, Megan L.
    Tetsu, Osamu
    van Zante, Annemieke
    Wang, Steven J.
    LARYNGOSCOPE, 2014, 124 (07): : E267 - E273
  • [4] TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas
    Brown, Noah A.
    Plouffe, Komal R.
    Yilmaz, Osman
    Weindorf, Steven C.
    Betz, Bryan L.
    Carey, Thomas E.
    Seethala, Raja R.
    McHugh, Jonathan B.
    Tomlins, Scott A.
    Udager, Aaron M.
    MODERN PATHOLOGY, 2021, 34 (06) : 1133 - 1142
  • [5] TP53 and CDKN2A mutations in patients with early-stage lung squamous cell carcinoma: an analysis of the correlations and prognostic outcomes
    Wang, Peiyuan
    Wang, Feng
    He, Hao
    Chen, Yujie
    Lin, Hui
    Chen, Peng
    Chen, Xiaofeng
    Liu, Shuoyan
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (16)
  • [6] Genetic Aberrations in CDKN2a and TP53 Genes in Patients With Laryngeal Carcinoma
    Todorova, T.
    Jordanov, S.
    Stancheva, G.
    Mitkova, A.
    Chalakov, I.
    Kaneva, R.
    Mitev, V.
    Melnicharov, M.
    Goranova, T.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S122 - S122
  • [7] Detection and Correlation of Single and Concomitant TP53, PTEN, and CDKN2A Alterations in Gliomas
    Pessoa, Igor Andrade
    Amorim, Carolina Koury
    Silva Ferreira, Wallax Augusto
    Sagica, Fernanda
    Brito, Jose Reginaldo
    Othman, Moneeb
    Meyer, Britta
    Liehr, Thomas
    de Oliveira, Edivaldo Herculano C.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (11)
  • [8] CDKN2A and TP53 mutational analysis in metastatic squamous cell carcinoma of the skin
    Kuesters-Vandevelde, Heidi V. N.
    Van Leeuwen, Arjanne
    Verdijk, Marian A. J.
    de Koning, Maurits N. C.
    Quint, Wim G. V.
    Melchers, Willem J. G.
    Ligtenberg, Marjolijn J. L.
    Blokx, Willeke A. M.
    VIRCHOWS ARCHIV, 2008, 452 : S103 - S103
  • [9] Mutational Status of CDKN2A and TP53 Genes in Laryngeal Squamous Cell Carcinoma
    Todorova, Teodora A.
    Jordanov, Stanislav H.
    Stancheva, Gergana S.
    Chalakov, Ivan J.
    Melnicharov, Mincho B.
    Kunev, Kuncho V.
    Mitev, Vanio I.
    Kaneva, Radka P.
    Goranova, Teodora E.
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (02) : 413 - 421
  • [10] Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer
    Stefanoudakis, Dimitrios
    Frountzas, Maximos
    Schizas, Dimitrios
    Michalopoulos, Nikolaos V.
    Drakaki, Alexandra
    Toutouzas, Konstantinos G.
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (04) : 2827 - 2844
12345